Show simple item record

dc.contributor.authorRickard, C
dc.contributor.authorMarsh, N
dc.contributor.authorLarsen, E
dc.contributor.authorCorley, A
dc.contributor.authorSpooner, A
dc.contributor.authorFraser, J
dc.contributor.authorDavis, C
dc.contributor.authorLepelaar, S
dc.contributor.authorLong, D
dc.contributor.authorRoberts, B
dc.contributor.authorBaker, S
dc.contributor.authorGill, F
dc.contributor.authorGowardman, J
dc.contributor.authorMurgo, M
dc.contributor.authorAlexandrou, E
dc.contributor.authorPalermo, A
dc.contributor.authorRegli, A
dc.contributor.authorMcGrail, M
dc.contributor.authorRunnegar, N
dc.date.accessioned2020-05-19T10:28:44Z
dc.date.available2020-05-19T10:28:44Z
dc.date.issued2018
dc.identifier.issn1036-7314
dc.identifier.doi10.1016/j.aucc.2017.12.008
dc.identifier.urihttp://hdl.handle.net/10072/394023
dc.description.abstractObjectives: To compare the effectiveness of 4-and 7-day routine administration set replacement for the prevention of infection. Methods: This multi-centre randomised controlled trial was funded by the National Health and Medical Research Council.
dc.languageEnglish
dc.publisherElsevier
dc.relation.ispartofconferencenameThe 42nd Australian and New Zealand Annual Scientific meeting on Intensive Care and the 23rd Annual Paediatric and Neonatal Intensive Care Conference
dc.relation.ispartofconferencetitleAUSTRALIAN CRITICAL CARE
dc.relation.ispartofdatefrom2017-10-11
dc.relation.ispartofdateto2017-10-13
dc.relation.ispartoflocationGold Coast, Australia
dc.relation.ispartofpagefrom114
dc.relation.ispartofpagefrom1 pages
dc.relation.ispartofpageto114
dc.relation.ispartofpageto1 pages
dc.relation.ispartofissue2
dc.relation.ispartofvolume31
dc.subject.fieldofresearchClinical sciences
dc.subject.fieldofresearchNursing
dc.subject.fieldofresearchcode3202
dc.subject.fieldofresearchcode4205
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsCritical Care Medicine
dc.subject.keywordsGeneral & Internal Medicine
dc.titleIntravenous administration set (infusion tubing) replacement after 4 or 7 days is equally effective to prevent bloodstream infections (RSVP trial)
dc.typeConference output
dc.type.descriptionE3 - Conferences (Extract Paper)
dcterms.bibliographicCitationRickard, C; Marsh, N; Larsen, E; Corley, A; Spooner, A; Fraser, J; Davis, C; Lepelaar, S; Long, D; Roberts, B; Baker, S; Gill, F; Gowardman, J; Murgo, M; et al., Intravenous administration set (infusion tubing) replacement after 4 or 7 days is equally effective to prevent bloodstream infections (RSVP trial), Australian Critical Care, 2018, 31 (2), pp. 114-114
dc.date.updated2020-05-19T10:26:33Z
gro.hasfulltextNo Full Text
gro.griffith.authorCorley, Amanda
gro.griffith.authorLarsen, Emily N.


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Conference outputs
    Contains papers delivered by Griffith authors at national and international conferences.

Show simple item record